STRO — SUTRO BIOPHARMA INC

Ownership history in Cerity Partners LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which Cerity Partners LLC reported a position in SUTRO BIOPHARMA INC (STRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 68,061 -37,376 -35.4% 0.00% $59K $8.70
2025 Q2 ADDED 105,437 +66,372 +169.9% 0.00% $75K $7.10
2025 Q1 ADDED 39,065 +27,754 +245.4% 0.00% $25K $6.50
2024 Q3 INITIATED 11,311 — — 0.00% $39K $34.60
% of Fund (quarterly)    STRO price (monthly, adj. close)

Other funds also holding STRO

As of 2025 Q4 — sorted by position size

Velan Capital Investment Management LP 3Y 2.09% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 0.53% Affinity Asset Advisors, LLC 3Y 0.49% Kynam Capital Management, LP 3Y 0.35% Opaleye Management Inc. 3Y 7Y 0.29% Samsara BioCapital, LLC 3Y 7Y 0.24% Eversept Partners, LP 3Y 7Y 0.11% Vestal Point Capital, LP 0.1% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.09% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.08%
← Back to Cerity Partners LLC Holdings